Asterand Extends Research Agreement with Bristol-Myers Squibb

BMS will continue to use Asterand's tissue-based drug-discovery products and services for up to three years.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.